PaxMedica, Inc.
PXMD
$0.00
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 771.00K | 1.49M | 3.30M | 3.22M | 2.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 887.90K | 3.00M | 3.69M | 4.39M | 4.36M |
| Operating Income | -887.90K | -3.00M | -3.69M | -4.39M | -4.36M |
| Income Before Tax | -876.60K | -3.00M | -3.69M | -5.92M | -5.05M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -876.60K | -3.00M | -3.69M | -5.92M | -5.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -876.60K | -3.00M | -3.69M | -5.92M | -5.05M |
| EBIT | -887.90K | -3.00M | -3.69M | -4.39M | -4.36M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.10 | -0.39 | -0.50 | -1.45 | -5.20 |
| Normalized Basic EPS | -0.06 | -0.24 | -0.31 | -0.96 | -3.02 |
| EPS Diluted | -0.10 | -0.39 | -0.50 | -1.45 | -5.20 |
| Normalized Diluted EPS | -0.06 | -0.24 | -0.31 | -0.96 | -3.02 |
| Average Basic Shares Outstanding | 9.06M | 7.66M | 7.42M | 4.07M | 971.80K |
| Average Diluted Shares Outstanding | 9.06M | 7.66M | 7.42M | 4.07M | 971.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |